| Identification | Back Directory |  [Name]
  L-Leucine, N-[2-oxo-2-(2-phenyl-1H-indol-3-yl)acetyl]-L-phenylalanyl-, methyl ester |  [CAS]
  1917350-09-4 |  [Synonyms]
  MDM2-p53-IN-16 L-Leucine, N-[2-oxo-2-(2-phenyl-1H-indol-3-yl)acetyl]-L-phenylalanyl-, methyl ester |  [Molecular Formula]
  C32H33N3O5 |  [MOL File]
  1917350-09-4.mol |  [Molecular Weight]
  539.62 |  
 | Hazard Information | Back Directory |  [Uses]
  MDM2-p53-IN-16 is a MDM2-p53 complex inhibitor with an IC50 value of 4.3 nM to dissociate human p53/MDM2 complex. MDM2-p53-IN-16 reactivates p53, and induces Glioblastoma Multiforme (GBM) cell apoptosis and cell-cycle arrest. MDM2-p53-IN-16 can be used for the cancer research[1]. |  [References]
  [1] Daniele S, et al. Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas. J Med Chem. 2016 May 26;59(10):4526-38. DOI:10.1021/acs.jmedchem.5b01767 |  
  
             | 
            
            
                
                
                
                
                
                
                
                
                
                
                
                
                
             |